SP
JNJ icon

Saranac Partners’s Johnson & Johnson JNJ Stock Holding History

Saranac Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$686K Buy
15,632
+13,995
+855% +$3.26M 0.29% 53
2025
Q4 		$339K Buy
1,637
+155
+10% +$30.7K 0.13% 61
2025
Q3 		$275K Buy
1,482
+110
+8% +$18.8K 0.05% 178
2025
Q2 		$210K Buy
+1,372
New +$211K 0.11% 66
2023
Q4 		– Sell
-1,376
Closed -$214K – 88
2023
Q3 		$214K Hold
1,376
– – 0.12% 73
2023
Q2 		$228K Hold
1,376
– – 0.12% 77
2023
Q1 		$213K Buy
+1,376
New +$222K 0.13% 78

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Saranac Partners's JNJ Position: Q1 2026 in Review

Saranac Partners increased its Johnson & Johnson (JNJ) stake by 855% in Q1 2026, buying an estimated $3.26M and bringing the position to 15,632 shares worth $686K. The position accounts for 0.29% of the portfolio, ranked #53.

Saranac Partners first reported a position in JNJ in Q1 2023 and has held it in 7 quarters since. 4,632 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Saranac Partners held 15,632 shares of Johnson & Johnson worth $686K as of Q1 2026.
  • Saranac Partners bought 13,995 Johnson & Johnson shares in Q1 2026, an estimated $3.26M.
  • Johnson & Johnson made up 0.29% of Saranac Partners's portfolio in Q1 2026, its #53 holding.
  • Saranac Partners first reported a position in Johnson & Johnson in Q1 2023 and has held it in 7 quarters since.
  • 4,632 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Saranac Partners's 13F filing for Q1 2026, filed 15 May 2026.